Our results are consistent with the study by Tsuchiya et al., who reported that YTHDF1 and YTHDF2 were associated with a better prognosis and an inflamed tumor‐immune microenvironment in NSCLC by regulating the expression of PD‐1 and PD‐L1.78 The gene discussed is CD274; the disease is neoplasm.